With much of the world focused on the response to COVID-19, many biopharmaceuticals are looking at new ways that they ...

Many pharmaceutical products, including vaccines, can require special cold chain handling during manufacturing and distribution. In particular, biologics such as ...

The impact of COVID-19, better known as coronavirus, is still unknown but there is clearly a significant humanitarian impact where ...

The global outbreak of the Coronavirus Disease (COVID-19) and its impact both socially and economically across the world’s continents has ...

On January 28, 2020, the highly anticipated final FDA gene therapy guidances were released. In total, 7 guidance documents were ...

The 2020 pharmaceutical trends reflect the broad shifts currently impacting the industry as it moves from the blockbuster model that ...

There is no doubt that AI represents an opportunity to transform the drug development and commercialization process and value that ...

The life sciences industry has experienced breakthroughs on multiple fronts over the past few years and 2019 was no different. ...

Increased globalization and the growing complexities around innovative, next-generation therapies has forced biopharmaceutical leaders to reexamine their clinical supply chain ...

In the age of precision and personalized medicine, life science companies can develop treatments designed to target almost any patient’s ...

On July 31, 2019, the White House announced an iterative healthcare plan that would allow the importation of Canadian drugs ...

Since the antihistamine brompheniramine maleate (i.e., Dimetapp today) made the switch from Rx to OTC in 1976, 115 more products ...